Skip to main content
Top
Published in: European Journal of Clinical Microbiology & Infectious Diseases 5/2006

01-05-2006 | Article

Antimicrobial resistance of Neisseria gonorrhoeae isolates from the Stuttgart and Heidelberg areas of southern Germany

Authors: M. Enders, A. Turnwald-Maschler, T. Regnath

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 5/2006

Login to get access

Abstract

The aim of the present study was to determine prospectively the antimicrobial susceptibility of Neisseria gonorrhoeae strains collected in southern Germany (Heidelberg and Stuttgart areas). Sixty-five N. gonorrhoeae strains, isolated between July 2004 and June 2005 from patients with uncomplicated gonorrhoea, were tested. Minimum inhibitory concentrations of penicillin, tetracycline, ciprofloxacin, azithromycin, spectinomycin, ceftriaxone, and cefixime were determined by the E test. All isolates were fully susceptible to ceftriaxone, cefixime, and spectinomycin. However, 21.5% (14/65), 29.2% (19/65), and 47.7% (31/65) of isolates were resistant to penicillin (>2.0 mg/l), tetracycline (>2.0 mg/l), and ciprofloxacin (>1.0 mg/l), respectively. Critical MICs of azithromycin (>1.0 mg/l, as defined by the Neisseria Reference Laboratory at the Centers for Disease Control) were found for five (7.7%) N. gonorrhoeae isolates. These data indicate a high prevalence of N. gonorrhoeae strains resistant to the antimicrobial agents currently used to treat gonococcal infections in the Heidelberg and Stuttgart areas. Even though the findings may not be representative of the general population in Germany, they nevertheless illustrate the need to establish an antimicrobial resistance surveillance system in order to control gonorrhoea effectively.
Literature
1.
go back to reference Fenton KA, Lowndes CM, and the European Surveillance of Sexually Transmitted Infections (ESSTI) Network (2004) Recent trends in the epidemiology of sexually transmitted infections in the European Union. Sex Transm Infect 80:255–263CrossRefPubMed Fenton KA, Lowndes CM, and the European Surveillance of Sexually Transmitted Infections (ESSTI) Network (2004) Recent trends in the epidemiology of sexually transmitted infections in the European Union. Sex Transm Infect 80:255–263CrossRefPubMed
2.
go back to reference Bremer V, Marcus U, Hofmann A, Hamouda O (2005) Building a sentinel surveillance system for sexually transmitted infections in Germany, 2003. Sex Transm Infect 81:173–179CrossRefPubMed Bremer V, Marcus U, Hofmann A, Hamouda O (2005) Building a sentinel surveillance system for sexually transmitted infections in Germany, 2003. Sex Transm Infect 81:173–179CrossRefPubMed
3.
go back to reference National Committee for Clinical Laboratory Standards (2004) Performance standards for antimicrobial susceptibility testing: twelfth informational supplement: M100-S14. Wayne, Pennsylvania, USA National Committee for Clinical Laboratory Standards (2004) Performance standards for antimicrobial susceptibility testing: twelfth informational supplement: M100-S14. Wayne, Pennsylvania, USA
5.
go back to reference Schäfer V, Enzensberger R, Schneider C, Rickmann J, Nitschke-Özbay H, Brade V (1995) Epidemiology of penicillin-resistant Neisseria gonorrhoeae in Frankfurt, Germany. Eur J Clin Microbiol Infect Dis 14:914–918CrossRefPubMed Schäfer V, Enzensberger R, Schneider C, Rickmann J, Nitschke-Özbay H, Brade V (1995) Epidemiology of penicillin-resistant Neisseria gonorrhoeae in Frankfurt, Germany. Eur J Clin Microbiol Infect Dis 14:914–918CrossRefPubMed
6.
go back to reference Wagner J, Tebbe B, Hörnle R, Chahin M, Arvand M, Wendt C, Orfanos CE, Hahn H (2000) Antibiotikaempfindlichkeit von Neisseria-gonorrhoeae-Isolaten in Berlin. Hautarzt 51:666–669CrossRefPubMed Wagner J, Tebbe B, Hörnle R, Chahin M, Arvand M, Wendt C, Orfanos CE, Hahn H (2000) Antibiotikaempfindlichkeit von Neisseria-gonorrhoeae-Isolaten in Berlin. Hautarzt 51:666–669CrossRefPubMed
7.
go back to reference Vogel F, Scholz H, Al-Nawas B, Elies W, Kresken M, Lode H, Müller O, Naber KG, Petersen E, Shah P, Sörgel F, Stille W, Tauchnitz C, Trautmann M, Ullmann U, Wacha H, Wiedemann B (2002) Rationaler Einsatz oraler Antibiotika bei Erwachsenen. Chemotherapie J 11:47–58CrossRef Vogel F, Scholz H, Al-Nawas B, Elies W, Kresken M, Lode H, Müller O, Naber KG, Petersen E, Shah P, Sörgel F, Stille W, Tauchnitz C, Trautmann M, Ullmann U, Wacha H, Wiedemann B (2002) Rationaler Einsatz oraler Antibiotika bei Erwachsenen. Chemotherapie J 11:47–58CrossRef
8.
go back to reference Lassus A (1990) Comparative studies of azithromycin in skin and soft-tissue infections and sexually transmitted infections by Neisseria and Chlamydia species. J Antimicrob Chemother 25(Suppl A):115–121PubMed Lassus A (1990) Comparative studies of azithromycin in skin and soft-tissue infections and sexually transmitted infections by Neisseria and Chlamydia species. J Antimicrob Chemother 25(Suppl A):115–121PubMed
9.
go back to reference Habib AR, Fernando R (2004) Efficacy of azithromycin 1 g single dose in the management of uncomplicated gonorrhoea. Int J STD AIDS 15:240–242CrossRefPubMed Habib AR, Fernando R (2004) Efficacy of azithromycin 1 g single dose in the management of uncomplicated gonorrhoea. Int J STD AIDS 15:240–242CrossRefPubMed
10.
go back to reference Martin DH, Mroczkowski TF, Dalu ZA, McCarty J, Jones RB, Hopkins SJ, Johnson RB (1992) A controlled trial of a single dose of azithromycin for the treatment of chlamydial urethritis and cervicitis. The Azithromycin for Chlamydial Infections Study Group. N Engl J Med 327:921–925PubMedCrossRef Martin DH, Mroczkowski TF, Dalu ZA, McCarty J, Jones RB, Hopkins SJ, Johnson RB (1992) A controlled trial of a single dose of azithromycin for the treatment of chlamydial urethritis and cervicitis. The Azithromycin for Chlamydial Infections Study Group. N Engl J Med 327:921–925PubMedCrossRef
11.
go back to reference Waugh MA (1993) Open study of the safety and efficacy of a single oral dose of azithromycin for the treatment of uncomplicated gonorrhoea in men and women. J Antimicrob Chemother 31(Suppl E):193–198PubMed Waugh MA (1993) Open study of the safety and efficacy of a single oral dose of azithromycin for the treatment of uncomplicated gonorrhoea in men and women. J Antimicrob Chemother 31(Suppl E):193–198PubMed
12.
go back to reference Young H, Moyes A, McMillan A (1997) Azithromycin and erythromycin resistant Neisseria gonorrhoeae following treatment with azithromycin. Int J STD AIDS 8:299–302CrossRefPubMed Young H, Moyes A, McMillan A (1997) Azithromycin and erythromycin resistant Neisseria gonorrhoeae following treatment with azithromycin. Int J STD AIDS 8:299–302CrossRefPubMed
13.
go back to reference Tapsall JW, Shultz TR, Limnios EA, Donovan B, Mulhall BP (1998) Failure of azithromycin therapy in gonorrhea and discorrelation with laboratory test parameters. Sex Transm Dis 25:505–508PubMedCrossRef Tapsall JW, Shultz TR, Limnios EA, Donovan B, Mulhall BP (1998) Failure of azithromycin therapy in gonorrhea and discorrelation with laboratory test parameters. Sex Transm Dis 25:505–508PubMedCrossRef
14.
go back to reference Handsfield HH, Dalu ZA, Martin DH, Douglas JM Jr, McCarty JM, Schlossberg D (1994) Multicenter trial of single-dose azithromycin vs. ceftriaxone in the treatment of uncomplicated gonorrhoea. Azithromycin Gonorrhoea Study Group. Sex Transm Dis 21:107–111PubMedCrossRef Handsfield HH, Dalu ZA, Martin DH, Douglas JM Jr, McCarty JM, Schlossberg D (1994) Multicenter trial of single-dose azithromycin vs. ceftriaxone in the treatment of uncomplicated gonorrhoea. Azithromycin Gonorrhoea Study Group. Sex Transm Dis 21:107–111PubMedCrossRef
15.
go back to reference Kent CK, Chaw JK, Wong W, Liska S, Gibson S, Hubbard G, Klausner J (2005) Prevalence of rectal, urethral, and pharyngeal chlamydia and gonorrhea detected in 2 clinical settings among men who have sex with men: San Francisco, California, 2003. Clin Infect Dis 41:67–74CrossRefPubMed Kent CK, Chaw JK, Wong W, Liska S, Gibson S, Hubbard G, Klausner J (2005) Prevalence of rectal, urethral, and pharyngeal chlamydia and gonorrhea detected in 2 clinical settings among men who have sex with men: San Francisco, California, 2003. Clin Infect Dis 41:67–74CrossRefPubMed
16.
go back to reference McCormack WM, Finland M (1976) Drugs five years later. Spectinomycin. Ann Intern Med 84:712–716PubMed McCormack WM, Finland M (1976) Drugs five years later. Spectinomycin. Ann Intern Med 84:712–716PubMed
18.
go back to reference Cohen MS, Pilcher CD (2005) Amplified HIV transmission and new approaches to HIV prevention. J Infect Dis 191:1391–1393CrossRefPubMed Cohen MS, Pilcher CD (2005) Amplified HIV transmission and new approaches to HIV prevention. J Infect Dis 191:1391–1393CrossRefPubMed
19.
go back to reference Tapsall JW (2005) Antibiotic resistance in Neisseria gonorrhoeae. Clin Infect Dis 41(Suppl 4):S263–S268CrossRefPubMed Tapsall JW (2005) Antibiotic resistance in Neisseria gonorrhoeae. Clin Infect Dis 41(Suppl 4):S263–S268CrossRefPubMed
Metadata
Title
Antimicrobial resistance of Neisseria gonorrhoeae isolates from the Stuttgart and Heidelberg areas of southern Germany
Authors
M. Enders
A. Turnwald-Maschler
T. Regnath
Publication date
01-05-2006
Publisher
Springer-Verlag
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 5/2006
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-006-0134-y

Other articles of this Issue 5/2006

European Journal of Clinical Microbiology & Infectious Diseases 5/2006 Go to the issue

Announcement

Announcement